Erik Thorud

1.4k total citations
50 papers, 1.2k citations indexed

About

Erik Thorud is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Erik Thorud has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Surgery. Recurrent topics in Erik Thorud's work include Cancer Genomics and Diagnostics (9 papers), Circadian rhythm and melatonin (5 papers) and Lung Cancer Research Studies (4 papers). Erik Thorud is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Circadian rhythm and melatonin (5 papers) and Lung Cancer Research Studies (4 papers). Erik Thorud collaborates with scholars based in Norway, United States and Denmark. Erik Thorud's co-authors include O. P. F. Clausen, Sophie D. Fosså, K. Elgjo, Torleiv O. Rognum, Eiliv Lund, Rolf Bjerknes, P Brandtzæg, Erik O. Pettersen, Mohammed Shoaib and Olav Kaalhus and has published in prestigious journals such as Cancer, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Erik Thorud

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Thorud Norway 22 405 348 289 248 228 50 1.2k
Luc Bron Switzerland 19 886 2.2× 196 0.6× 501 1.7× 268 1.1× 125 0.5× 30 1.7k
Jan Åkervall Sweden 20 418 1.0× 224 0.6× 564 2.0× 164 0.7× 80 0.4× 44 1.1k
Gerard Cowley United Kingdom 16 426 1.1× 122 0.4× 399 1.4× 138 0.6× 120 0.5× 27 1.0k
Malcolm J. Simons Australia 8 323 0.8× 195 0.6× 231 0.8× 95 0.4× 81 0.4× 16 846
Shin‐ichiro Takai Japan 21 295 0.7× 227 0.7× 351 1.2× 167 0.7× 169 0.7× 59 1.3k
Pilar España Spain 23 804 2.0× 588 1.7× 1.1k 3.9× 354 1.4× 331 1.5× 61 1.9k
Jiang Li China 20 486 1.2× 168 0.5× 421 1.5× 167 0.7× 100 0.4× 83 1.2k
Masahiko Tanabe Japan 15 290 0.7× 251 0.7× 323 1.1× 140 0.6× 148 0.6× 90 882
W. Michael Hogan United States 18 375 0.9× 116 0.3× 254 0.9× 164 0.7× 151 0.7× 33 1.3k

Countries citing papers authored by Erik Thorud

Since Specialization
Citations

This map shows the geographic impact of Erik Thorud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Thorud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Thorud more than expected).

Fields of papers citing papers by Erik Thorud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Thorud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Thorud. The network helps show where Erik Thorud may publish in the future.

Co-authorship network of co-authors of Erik Thorud

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Thorud. A scholar is included among the top collaborators of Erik Thorud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Thorud. Erik Thorud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaasa, S., et al.. (2015). Reduced Short-Term Neuropsychological Performance in Patients with Nonsmall-Cell Lung Cancer Treated with Cisplatin and Etoposide1. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 41. 226–231. 10 indexed citations
2.
Kaasa, Stein, Erik Thorud, Johan Tausjø, et al.. (1991). Phase I/II study of carboplatin and 5-fluorouracil in patients with advanced head and neck carcinoma. European Journal of Cancer and Clinical Oncology. 27(5). 576–579. 5 indexed citations
3.
Kaasa, Stein, Eiliv Lund, Erik Thorud, Reidulv Hatlevoll, & Herman Høst. (1991). Symptomatic treatmentversus combination chemotherapy for patients with extensive non-small cell lung cancer. Cancer. 67(10). 2443–2447. 59 indexed citations
4.
Vermund, Halvor, Morten Boysen, J. Evensen, et al.. (1990). Primary Irradiation, Surgery or Combined Therapy in Squamous Cell Carcinoma of the Larynx: A comparison of treatment results from two centers. Acta Oncologica. 29(4). 489–503. 19 indexed citations
5.
Elsås, Tor, et al.. (1988). Retinopathy after low dose irradiation for an intracranial tumor of the frontal lobe. Acta Ophthalmologica. 66(1). 65–68. 20 indexed citations
7.
Kaasa, Stein, et al.. (1988). A randomized study evaluating radiotherapy versus chemotheraphy in patients with inoperable non-small cell lung cancer. Radiotherapy and Oncology. 11(1). 7–13. 30 indexed citations
8.
Jacobsen, Anne-Birgitte, et al.. (1988). DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin‐embedded material. Apmis. 96(1-6). 25–29. 22 indexed citations
9.
Rognum, TO, Erik Thorud, & Eiliv Lund. (1987). Survival of large bowel carcinoma patients with different DNA ploidy. British Journal of Cancer. 56(5). 633–636. 65 indexed citations
10.
Vermund, Halvor, Anne-Birgitte Jacobsen, Olav Kaalhus, et al.. (1987). Changing Aspects in the Treatment of Squamous Cell Carcinoma of the Oral Tongue. Acta Oncologica. 26(3). 163–172. 9 indexed citations
11.
Thorud, Erik, et al.. (1987). Plasma CEA in large bowel carcinoma: which patients should be followed by regular postoperative measurements? Preliminary follow-up results in 100 patients with different tumor DNA-ploidy patterns.. PubMed. 10(5-6). 347–52. 5 indexed citations
12.
Jacobsen, Anne-Birgitte, et al.. (1987). DNA flow cytometry in metastases and a recurrency of malignant melanomas. Virchows Archiv B Cell Pathology Including Molecular Pathology. 54(1). 273–277. 22 indexed citations
13.
Thorud, Erik, Sophie D. Fosså, Sigmund Vaage, et al.. (1986). Primary breast cancer: Flow cytometric dna pattern in relation to clinical and histopathologic characteristics. Cancer. 57(4). 808–811. 73 indexed citations
14.
Vermund, Halvor, et al.. (1985). Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: A phase III clinical trial. International Journal of Radiation Oncology*Biology*Physics. 11(11). 1877–1886. 56 indexed citations
15.
Clausen, O. P. F., Olav Hilmar Iversen, & Erik Thorud. (1984). Circadian variation in the susceptibility of mouse epidermis to tumour induction by methylnitrosourea. Virchows Archiv B Cell Pathology Including Molecular Pathology. 45(1). 325–329. 9 indexed citations
16.
Thorud, Erik, et al.. (1981). Model analysis of circadian rhythms in mouse epidermal basal cell proliferation. Journal of Theoretical Biology. 88(2). 355–370. 20 indexed citations
17.
Iversen, Olav Hilmar, et al.. (1981). Inhibition of methylcholanthrene-induced skin carcinogenesis in hairless mice by dimethyl sulfoxide. Carcinogenesis. 2(11). 1129–1133. 4 indexed citations
18.
Thorud, Erik, et al.. (1980). Perturbation of Cell Cycle Progression in Mouse Epidermis Prior to the Regenerative Response. Journal of Investigative Dermatology. 74(6). 433–436. 9 indexed citations
19.
Clausen, O. P. F., Erik Thorud, Rolf Bjerknes, & K. Elgjo. (1979). CIRCADIAN RHYTHMS IN MOUSE EPIDERMAL BASAL CELL PROLIFERATION. Cell Proliferation. 12(3). 319–337. 96 indexed citations
20.
Thorud, Erik, et al.. (1978). Epidermla cell kinetics in hairless mice after bleomycin. I. Perturbations after different single doses.. PubMed. 62(3). 351–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026